Header Logo

Takemi Tanaka

TitleProf
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentStephenson Cancer Center
AddressBRC 1413
975 NE 10th St
Oklahoma City OK 73104
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    R01CA160271     (TANAKA, TAKEMI)Apr 1, 2012 - Mar 31, 2018
    NIH
    Anti-Migration Therapy for Prevention and Treatment of Breast Tumor
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Simmons R, Kameyama H, Kubota S, Sun Y, Langenheim JF, Ajeeb R, Shao TS, Ricketts S, Annan AC, Stratemeier N, Williams SJ, Clegg JR, Fung KM, Chervoneva I, Rui H, Tanaka T. Sustained delivery of celecoxib from nanoparticles embedded in hydrogel injected into the biopsy cavity to prevent biopsy-induced breast cancer metastasis. Breast Cancer Res Treat. 2024 Jul 05. PMID: 38969944.
      Citations:    Fields:    Translation:HumansAnimalsCells
    2. Leslie M, Pathak R, Dooley WC, Squires RA, Rui H, Chervoneva I, Tanaka T. Surgical Delay-Associated Mortality Risk Varies by Subtype in Loco-Regional Breast Cancer Patients in SEER-Medicare. Res Sq. 2024 Apr 08. PMID: 38659868; PMCID: PMC11042396.
      Citations:    
    3. Kameyama H, Dondapati P, Simmons R, Leslie M, Langenheim JF, Sun Y, Yi M, Rottschaefer A, Pathak R, Nuguri S, Fung KM, Tsaih SW, Chervoneva I, Rui H, Tanaka T. Needle biopsy accelerates pro-metastatic changes and systemic dissemination in breast cancer: Implications for mortality by surgery delay. Cell Rep Med. 2023 Dec 19; 4(12):101330. PMID: 38118415.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    4. Pathak R, Leslie M, Dondapati P, Davis R, Tanaka K, Jett E, Chervoneva I, Tanaka T. Increased breast cancer mortality due to treatment delay and needle biopsy type: a retrospective analysis of SEER-medicare. Breast Cancer. 2023 May 03. PMID: 37130988.
      Citations: 2     Fields:    Translation:Humans
    5. Ding Y, Chen J, Li S, Wren JD, Bajpai AK, Wang J, Tanaka T, Rice HC, Hays FA, Lu L, Zhang XA. EWI2 and its relatives in Tetraspanin-enriched membrane domains regulate malignancy. Oncogene. 2023 03; 42(12):861-868. PMID: 36788350.
      Citations: 2     Fields:    Translation:HumansAnimals
    6. Fu C, Wang J, Pallikkuth S, Ding Y, Chen J, Wren JD, Yang Y, Wong KK, Kameyama H, Jayaraman M, Munshi A, Tanaka T, Lidke KA, Zhang XA. EWI2 prevents EGFR from clustering and endocytosis to reduce tumor cell movement and proliferation. Cell Mol Life Sci. 2022 Jun 30; 79(7):389. PMID: 35773608.
      Citations: 2     Fields:    Translation:HumansCells
    7. McCarty C, Yi M, Sous S, Leslie M, Tariq E, Dondapati P, Kameyama H, Nuguri S, Hills N, Wilkerson M, Davis R, Mesiya S, Rui H, Chervoneva I, Zhang R, Tanaka T. Sustained Inflammation of Breast Tumors after Needle Biopsy. Pathobiology. 2022 Jun 01; 1-9. PMID: 35649384.
      Citations: 3     Fields:    Translation:Humans
    8. Hills N, Leslie M, Davis R, Crowell M, Kameyama H, Rui H, Chervoneva I, Dooley W, Tanaka T. Prolonged Time from Diagnosis to Breast-Conserving Surgery is Associated with Upstaging in Hormone Receptor-Positive Invasive Ductal Breast Carcinoma. Ann Surg Oncol. 2021 Oct; 28(11):5895-5905. PMID: 33748899.
      Citations: 9     Fields:    Translation:Humans
    9. Hills N, Leslie M, Davis R, Crowell M, Kamemyama H, Rui H, Chervoneva I, Dooley W, Tanaka T. ASO Author Reflections: Does Prompt Breast-Conserving Surgery Matter? Ann Surg Oncol. 2021 10; 28(11):5906. PMID: 33666812.
      Citations:    Fields:    Translation:Humans
    10. Morita Y, Leslie M, Kameyama H, Lokesh GLR, Ichimura N, Davis R, Hills N, Hasan N, Zhang R, Kondo Y, Gorenstein DG, Volk DE, Chervoneva I, Rui H, Tanaka T. Functional Blockade of E-Selectin in Tumor-Associated Vessels Enhances Anti-Tumor Effect of Doxorubicin in Breast Cancer. Cancers (Basel). 2020 Mar 19; 12(3). PMID: 32204492.
      Citations: 3     
    11. Morita Y, Leslie M, Kameyama H, Volk DE, Tanaka T. Aptamer Therapeutics in Cancer: Current and Future. Cancers (Basel). 2018 Mar 19; 10(3). PMID: 29562664.
      Citations: 72     
    12. Horton CE, Kamal M, Leslie M, Zhang R, Tanaka T, Razaq M. Circulating Tumor Cells Accurately Predicting Progressive Disease After Treatment in a Patient with Non-small Cell Lung Cancer Showing Response on Scans. Anticancer Res. 2018 02; 38(2):1073-1076. PMID: 29374743.
      Citations: 7     Fields:    Translation:HumansCells
    13. Morita Y, Zhang R, Leslie M, Adhikari S, Hasan N, Chervoneva I, Rui H, Tanaka T. Pathologic evaluation of tumor-associated macrophage density and vessel inflammation in invasive breast carcinomas. Oncol Lett. 2017 Aug; 14(2):2111-2118. PMID: 28789438.
      Citations: 18     
    14. Morita Y, Kamal M, Kang SA, Zhang R, Lokesh GL, Thiviyanathan V, Hasan N, Woo S, Zhao D, Leslie M, Suh S, Razaq W, Rui H, Gorenstein DG, Volk DE, Tanaka T. E-selectin Targeting PEGylated-thioaptamer Prevents Breast Cancer Metastases. Mol Ther Nucleic Acids. 2016 Dec 13; 5(12):e399. PMID: 27959340.
      Citations: 12     
    15. Kang SA, Blache CA, Bajana S, Hasan N, Kamal M, Morita Y, Gupta V, Tsolmon B, Suh KS, Gorenstein DG, Razaq W, Rui H, Tanaka T. Erratum to: The effect of soluble E-selectin on tumor progression and metastasis. BMC Cancer. 2016 06 28; 16(1):370. PMID: 27353033.
      Citations: 1     Fields:    
    16. Kang SA, Blache CA, Bajana S, Hasan N, Kamal M, Morita Y, Gupta V, Tsolmon B, Suh KS, Gorenstein DG, Razaq W, Rui H, Tanaka T. The effect of soluble E-selectin on tumor progression and metastasis. BMC Cancer. 2016 05 24; 16:331. PMID: 27220365.
      Citations: 28     Fields:    Translation:HumansAnimalsCells
    17. Kang SA, Bajana S, Tanaka T. In vitro Flow Adhesion Assay for Analyzing Shear-resistant Adhesion of Metastatic Cancer Cells to Endothelial Cells. Bio Protoc. 2016 Feb 20; 6(4). PMID: 29333476.
      Citations: 3     
    18. Kang SA, Tsolmon B, Mann AP, Zheng W, Zhao L, Zhao YD, Volk DE, Lokesh GL, Morris L, Gupta V, Razaq W, Rui H, Suh KS, Gorenstein DG, Tanaka T. Safety evaluation of intravenously administered mono-thioated aptamer against E-selectin in mice. Toxicol Appl Pharmacol. 2015 Aug 15; 287(1):86-92. PMID: 26048585.
      Citations: 10     Fields:    Translation:Animals
    19. Kang SA, Hasan N, Mann AP, Zheng W, Zhao L, Morris L, Zhu W, Zhao YD, Suh KS, Dooley WC, Volk D, Gorenstein DG, Cristofanilli M, Rui H, Tanaka T. Blocking the adhesion cascade at the premetastatic niche for prevention of breast cancer metastasis. Mol Ther. 2015 Jun; 23(6):1044-1054. PMID: 25815697.
      Citations: 31     Fields:    Translation:HumansAnimalsCells
    Tanaka's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (73)
    Explore
    _
    Co-Authors (15)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _